TNF and epilepsy: What's more, the dysregulation of TNF and IER3 pathways in PM‐associated epilepsy suggests therapeutic potential for targeted immunomodulation (e.g., TNF signaling blockade), which may mitigate seizure susceptibility in high‐risk patients.